Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
About this item
Full title
Author / Creator
Publisher
Copernicus GmbH
Journal title
Language
English
Formats
Publication information
Publisher
Copernicus GmbH
Subjects
More information
Scope and Contents
Contents
We describe a 79-year-old man with spondylodiscitis and unknown
pathogen, treated with cefazolin and rifampicin. He developed a massive
digestive hemorrhage. Prothrombin time was prolonged with severe
vitamin-K-dependent clotting-factor deficiency. Severe bleeding can occur
during cefazolin and rifampicin use. This deficiency should be...
Alternative Titles
Full title
Coagulation disorders during treatment with cefazolin and rifampicin: rare but dangerous
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_dfb4edcb1fdf4238a92dd7dfb8b1f302
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_dfb4edcb1fdf4238a92dd7dfb8b1f302
Other Identifiers
ISSN
2206-3552
E-ISSN
2206-3552
DOI
10.5194/jbji-6-131-2021
